Potsdam (Germany), 05.04.2022. The Potsdam-based company Data4Life is expanding its research activities around the collection of real-world data. In January 2022, the non-profit organization launched the digital female health study FeMFit…
Presentation at ACC.22 shows early treatment of high-risk NSTEMI patients guided by continuous arrhythmia monitoring with ICMs may reduce major adverse cardiac events (MACE)
Berlin, 30 March 2022. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) achieved sales of EUR 180.4 million in fiscal year 2021 (previous year: EUR 176.1 million). The consolidated net income for the year reached a new…
Planned investments of around €2bn over next three years / Shift of resources into strategic pharmaceutical areas by investing in key production sites, manufacturing technologies and supply chain network / Bayer is transforming its pharmaceutical…
BIOTRONIK Patient App is available for patients with a compatible BIOTRONIK cardiac device
Berlin, 23 March 2022. Eckert & Ziegler (ISIN DE0005659700, TecDAX) has executed with the Canadian biotech company Alpha-9 Theranostics Inc. (Alpha-9) a clinical supply agreement for Eckert & Ziegler's medical radioisotope Lutetium-177…
Berlin, 22 March 2022. Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) and Sirtex Medical (Sirtex) have extended their long-term supply agreement for the use of yttrium-90 in Sirtex microspheres for the treatment of liver cancer to the Chinese…
Europe is facing a number of economic, environmental and social challenges, most notably the crisis in Ukraine, with businesses severely affected by supply chain disruptions. To address these challenges, the European Union (EU) has launched new mea…
Are you a startup or early-stage tech company from Germany interested in expanding into the United States? If so, then you are invited to apply to participate in the U.S Embassy’s Second Annual Startup SelectUSA Tech Pitch Competition on Thursday,…
Researchers at the Berlin Institute of Health in the Charité (BIH) have teamed up with colleagues from Cellbricks to develop a 3D printer that can produce a biological wound closure. The development is intended to reach high altitudes and help…
